Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Eleda in connection with acquisition of JVAB
Mandate

Vinge advises Eleda in connection with acquisition of JVAB

May 09, 2020 M&A EU, Competition and Regulatory Employment and Benefits Real Estate and Construction

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Järfälla VA- & Byggentreprenad AB (“JVAB”).

JVAB is focusing on civil engineering and transmission infrastructure in the Stockholm region. JVAB has around 150 employees and sales of approximately SEK 0.7 billion in 2019. The majority of JVAB is owned by the founding family, who will reinvest a significant portion in the combined Group. JVAB strengthens Eleda’s geographical coverage in the Stockholm area and has strong expertise in water works. The acquisition is carried out in connection with Altor Fund V’s acquisition of a majority stake in Eleda and Eleda’s acquisition of ONE Nordic.

Vinge’s team consisted of partner Christina Kokko together with associates Michaela Cronemyr, Manne Bergström, Hanna Risberg and Fredric Reissmüller (M&A), Trine Osen Bergqvist, Xandra Ståhlberg and Lisa Malmborg (Competition), Lisa Ullman (Employment), Rebecka Maltenius (Construction) and Nathalie Hughes (VDR assistant).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025